Alcon Buys Majority Stake in Aurion Biotech

MT Newswires17:00 ET

Aurion Board Appoints Arnaud Lacoste as CEO of Aurion

Dow Jones16:33 ET

Alcon: Aurion Will Operate as a Separate Company With Full Support From Alcon to Advance Its Clinical-Stage Allogeneic Cell Therapy Asset

Dow Jones16:32 ET

Leverages Alcon's Global Scale With Aurion's Cell Therapy Expertise to Accelerate U.S. Phase 3 Development in Fall of 2025 >ALC.EB

Dow Jones16:32 ET

Alcon Inc. Unit Alcon Research Previously Sued Aurion to Prevent It From Going Public

Dow Jones16:31 ET

Alcon Acquires Majority Interest in Aurion Biotech

Dow Jones16:30 ET